학술논문
Varicella‐zoster and herpes simplex virus reactivation post‐COVID‐19 vaccination: a review of 40 cases in an International Dermatology Registry.
Document Type
Article
Author
Source
Subject
*HERPES simplex virus
*HERPES zoster
*VIRUS reactivation
*CHICKENPOX
*COVID-19 pandemic
*MEDICAL personnel
*VACCINATION
*
*
*
*
*
*
Language
ISSN
0926-9959
Abstract
VZV reactivation has also been reported following SARS-CoV-2 infection itself, and a similar immunosuppressive mechanism has been suggested.10 Overall, COVID-19 vaccination is still recommended, as the benefits of COVID-19 vaccination vastly outweigh the potential risk of herpesvirus reactivation. Since December 2020, the American Academy of Dermatology and the International League of Dermatologic Societies' COVID-19 Dermatology Registry has tracked dermatologic reactions post-COVID-19 vaccination. Here, we evaluate the first 40 cases of varicella-zoster virus (VZV) and herpes simplex virus (HSV) reported in the registry after COVID-19 vaccination with either the Moderna or the Pfizer-BioNTech vaccines. [Extracted from the article]